Harmony Biosciences (HRMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Harmony Biosciences Holdings, Inc. (HRMY) and Illumina (ILMN). But which of these two ...

The global cannabis market was worth $26.86 billion in 2022, Spherical Insights & Consulting data shows. Three years later, ...

Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) is one of the most undervalued small-cap stocks to buy according to analysts.

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

Northern Lights Forecast: These 10 States Could See Aurora Borealis Wednesday NBA adjusts Gregg Popovich's career record, removes 77 games after all-time wins leader's extended absence Over 60,000 ...

Review Harmony Biosciences Holdings Inc Ordinary Shares (HRMY:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.